MARKET

IUGNF

IUGNF

Imugene
OTCPK
0.015
NaN%
Closed 09:30 05/19 EDT
OPEN
--
PREV CLOSE
0.015
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.055
52 WEEK LOW
0.014
MARKET CAP
112.01M
P/E (TTM)
-1.3761
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IUGNF last week (0512-0516)?
Weekly Report · 23h ago
Imugene Announces Proposed Share Consolidation to Enhance Market Position
TipRanks · 4d ago
Weekly Report: what happened at IUGNF last week (0505-0509)?
Weekly Report · 05/12 10:21
Weekly Report: what happened at IUGNF last week (0428-0502)?
Weekly Report · 05/05 10:22
Imugene Addresses Shareholder Concerns Amidst Market Challenges
TipRanks · 05/01 02:47
Weekly Report: what happened at IUGNF last week (0421-0425)?
Weekly Report · 04/28 10:28
Weekly Report: what happened at IUGNF last week (0414-0418)?
Weekly Report · 04/21 10:28
Weekly Report: what happened at IUGNF last week (0407-0411)?
Weekly Report · 04/14 10:21
More
About IUGNF
Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs.

Webull offers Imugene Ltd stock information, including OTCPK: IUGNF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IUGNF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IUGNF stock methods without spending real money on the virtual paper trading platform.